Mesoblast (MESO) had the highest return in March 2024 by a US stock with a market cap of $1B+, returning 151.8%.

ASSET	MONTH	% RETURN
Mesoblast (MESO)	March 2024	151.76%
Astera Labs, Inc Common Stock (ALAB)	March 2024	106.08%
Nuvation Bio (NUVB)	March 2024	95.7%
Apogee Therapeutics, Inc Common Stock (APGE)	March 2024	90.67%
Ehang (EH)	March 2024	88.37%
Sezzle (SEZL)	March 2024	87.71%
WM Technology (MAPSW)	March 2024	85.19%
TheRealReal (REAL)	March 2024	81.02%
Root (ROOT)	March 2024	77.76%
Stoke Therapeutics (STOK)	March 2024	74.42%
Cipher Mining (CIFR)	March 2024	71.67%
MicroStrategy (MSTR)	March 2024	71.14%
Nuscale Power (SMR)	March 2024	70.19%
Trump Media & Technology (DJTWW)	March 2024	68.51%
GCM Grosvenor (GCMGW)	March 2024	66.09%
Endeavour Silver (EXK)	March 2024	62.84%
Trump Media & Technology (DJT)	March 2024	61.02%
Qilian International (BGM)	March 2024	59.72%
Advantage Solutions (ADVWW)	March 2024	52.94%
Nextnav Acquisition (NN)	March 2024	52.67%
ATRenew Inc DRC (RERE)	March 2024	51.72%
DXP Enterprises (DXPE)	March 2024	51.69%
CompoSecure (CMPO)	March 2024	48.15%
Ouster, Inc Common Stock (OUST)	March 2024	47.04%
Equinox Gold (EQX)	March 2024	46.83%